Cui Xiaohong, Adler Stuart P, Davison Andrew J, Smith Larry, Habib El-Sayed E, McVoy Michael A
Department of Pediatrics, Medical College of Virginia Campus of Virginia Commonwealth University, 1101 E. Marshall Street, P.O. Box 980163, Richmond, VA 23298-0163, USA.
J Biomed Biotechnol. 2012;2012:428498. doi: 10.1155/2012/428498. Epub 2011 Nov 30.
Bacterial artificial chromosome (BAC) clones have proven invaluable for genetic manipulation of herpesvirus genomes. BAC cloning can also be useful for capturing representative genomes that comprise a viral stock or mixture. The Towne live attenuated cytomegalovirus vaccine was developed in the 1970s by serial passage in cultured fibroblasts. Although its safety, immunogenicity, and efficacy have been evaluated in nearly a thousand human subjects, the vaccine itself has been little studied. Instead, genetic composition and in vitro growth properties have been inferred from studies of laboratory stocks that may not always accurately represent the viruses that comprise the vaccine. Here we describe the use of BAC cloning to define the genotypic and phenotypic properties of viruses from the Towne vaccine. Given the extensive safety history of the Towne vaccine, these BACs provide a logical starting point for the development of next-generation rationally engineered cytomegalovirus vaccines.
细菌人工染色体(BAC)克隆已被证明在疱疹病毒基因组的基因操作中具有极高价值。BAC克隆对于捕获构成病毒株或混合物的代表性基因组也很有用。汤氏减毒活巨细胞病毒疫苗是在20世纪70年代通过在培养的成纤维细胞中连续传代而研发的。尽管其安全性、免疫原性和有效性已在近千名人类受试者中进行了评估,但对该疫苗本身的研究却很少。相反,其基因组成和体外生长特性是从对实验室毒株的研究中推断出来的,而这些毒株可能并不总是准确代表构成疫苗的病毒。在此,我们描述了使用BAC克隆来确定汤氏疫苗中病毒的基因型和表型特性。鉴于汤氏疫苗广泛的安全历史,这些BAC为开发下一代合理设计的巨细胞病毒疫苗提供了一个合理的起点。